Figures & data
Figure 1. Color fundus photograph and spectral domain–optical coherence tomography (OPKO/OTI Spectral OCT/SLO, OPKO Health, Inc. Miami, Florida) images of the left eye show (A) a full-thickness macular hole before, (B) macular hole closure with subretinal fluid accumulation 1 month after, and (C) complete macular hole closure 4 months after the initiation of interferon alfa-2a therapy.
![Figure 1. Color fundus photograph and spectral domain–optical coherence tomography (OPKO/OTI Spectral OCT/SLO, OPKO Health, Inc. Miami, Florida) images of the left eye show (A) a full-thickness macular hole before, (B) macular hole closure with subretinal fluid accumulation 1 month after, and (C) complete macular hole closure 4 months after the initiation of interferon alfa-2a therapy.](/cms/asset/9fa74ca7-4574-4442-a779-ad57eec44285/ioii_a_829107_f0001_b.jpg)